The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Bayer Confirms Discussions on Acquisition of Monsanto (2016-05-19)
Bayer executives recently met with executives of Monsanto to privately discuss a negotiated acquisition of Monsanto Company. The proposed combination would reinforce Bayer as a global innovation-driven Life Science company with leadership positions in its core s...
- Qiagen Extends Tender Offer Period for Acquisition of Exiqon (2016-05-19)
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the extension of the offer period for the acquisition of Exiqon A/S, a world leader in RNA technology. On 18 April 2016, QIAGEN had published a conditional, voluntary public tender offer for ...
- UK Catapult and University of Aberdeen Create Islexa Ltd (2016-05-18)
UK technology has potential to bring islet transplant therapy to thousands of patients with type 1 diabetes The Cell and Gene Therapy Catapult (CGT) and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technol...
- Merus Prices $55m IPO at Nasdaq Global Market (2016-05-18)
Merus B.V. (“Merus”) today announced the pricing of its initial public offering of 5,500,000 common shares at an initial public offering price of $10.00 per share, before underwriting discounts and commissions. All of the common shares are being offered by Merus. I...
- Siemens Healthcare GmbH Acquires NEO New Oncology AG (2016-05-17)
> Acquisition is part of Siemens Healthineers' strategy to become a trusted and holistic partner for healthcare providers > Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics Sie...
- Nouscom AG Concludes €12m Series A Financing Round (2016-05-17)
Nouscom announced today that it has closed a EUR 12 million Series A financing co-led by LSP and Versant Ventures. The funds will be used to support discovery and development of personalized cancer vaccines and tumor selective oncolytic viruses. “We are pleased ...
- Bayer Licenses CRISPR Patent from ERS Genomics (Charpentier) (2016-05-17)
The agreement offers broad access to research applications via promising CRISPR-Cas9 gene editing technology Bayer and ERS signed a patent license agreement whereby Bayer gains access to ERS’ CRISPR-Cas9 genome-editing patents for certain cross-divisional appl...
- Ardigen Provides Bioinformatics Support to EpiBiome (2016-05-17)
Ardigen, a bioinformatics company combining bio-data science and complementary advanced software support, is providing bioinformatics and software development services to EpiBiome, a precision microbiome engineering company based in California, US. The scope of ...
- Novartis Creates Two Pharma Business Units, Epstein Leaves (2016-05-17)
> Paul Hudson appointed CEO, Novartis Pharmaceuticals, and Bruno Strigini appointed CEO, Novartis Oncology; David Epstein to leave Novartis > Paul Hudson and Bruno Strigini appointed to the Executive Committee of Novartis > Novartis Pharmaceuticals and Novart...
- Pfizer to Acquire Anacor for $5.2b Net of Cash (2016-05-16)
> Expected to enhance near-term revenue growth for the innovative business > Anacor’s flagship asset, crisaborole, has a New Drug Application under review by the U.S. Food and Drug Administration (FDA), is a differentiated non-steroidal topical PDE4 inhibitor wi...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to email@example.com and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]